← SynDRA
MIZOLASTINE
SynDRA canonical compound SYN0003760 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | allergic rhinitis | urticaria |
|---|
| Disease area | allergy |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRM1
- PDE3A
- ADORA1
- HRH3
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- HDAC6
- OPRK1
- OPRM1
- PDE4D
- PGR
- PTGS2
- SAMHD1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH2
- GMNN
- ADORA2A
- GHSR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Histamine H1 Antagonists, Non-Sedating
- Neurotransmitter Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- SL 85.0324
- mistamine
- mizollen
- zolistan
- Mizolastina
- Mizollen
- Mistalin
- Mistamine
- Mizolastinum
- Mizolen
- Zolim
- Zolistam
- Zolistan
- Allphar brand of mizolastine
- Galderma brand of mizolastine
- Mizolastine [INN]
- Novag brand of mizolastine
- Sanofi Synthelabo brand of mizolastine
- Schwarz brand of mizolastine
- MKC-431
- Mizolastina [INN-Spanish]
- Mizolastinum [INN-Latin]
- Mizollen (TN)
- SL-85.0324
- Mizolastine (JAN/INN)
- 2-((1-(1-(p-Fluorobenzyl)-2-benzimidazolyl)-4-piperidyl)methylamino)-4(3H)-pyrimidinone
- 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one
- DTXCID3026801
- RefChem:819015
- R06AX25
- C24H25FN6O
- Mizolastine (Mizollen)
- NCGC00181013-01
- CAS-108612-45-9
- Mizolastine [INN:BAN]
- UNII-244O1F90NA
- CCRIS 8410
- MFCD23140913
Look up MIZOLASTINE in the interactive SynDRA portal →